Frontiers in Immunology (Sep 2022)

Clinical application of transcranial magnetic stimulation in multiple sclerosis

  • Xiaoliang Zhou,
  • Xiaoliang Zhou,
  • Kailin Li,
  • Kailin Li,
  • Si Chen,
  • Si Chen,
  • Wenbin Zhou,
  • Wenbin Zhou,
  • Jing Li,
  • Jing Li,
  • Qing Huang,
  • Qing Huang,
  • Tingting Xu,
  • Zhiyuan Gao,
  • Dongyu Wang,
  • Shuo Zhao,
  • Hao Dong

DOI
https://doi.org/10.3389/fimmu.2022.902658
Journal volume & issue
Vol. 13

Abstract

Read online

Multiple sclerosis (MS) is a common chronic, autoimmune-mediated inflammatory and neurodegenerative disease of the central nervous system. The treatment of MS has enormous progress with disease-modifying drugs, but the complexity of the disease course and the clinical symptoms of MS requires personalized treatment and disease management, including non-pharmacological treatment. Transcranial magnetic stimulation (TMS) is a painless and non-invasive brain stimulation technique, which has been widely used in neurological diseases. In this review, we mainly focus on the progress of physiological assessment and treatment of TMS in MS.

Keywords